Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88243803 |
LAW OFFICE ASSIGNED |
LAW OFFICE 115 |
MARK SECTION |
MARK |
LYZADDIS (see, http://uspto.report/TM/88243803/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
LYZADDIS |
OWNER SECTION (current) |
NAME |
SillaJen, Inc. |
INTERNAL ADDRESS |
Suite 607 |
MAILING ADDRESS |
6th Floor, 111, Hyoyeol-ro, Buk-gu |
CITY |
Busan |
ZIP/POSTAL CODE |
46508 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Korea, South |
EMAIL |
XXXX |
OWNER SECTION (proposed) |
NAME |
SillaJen, Inc. |
INTERNAL ADDRESS |
Suite 607 |
MAILING ADDRESS |
6th Floor, 111, Hyoyeol-ro, Buk-gu |
CITY |
Busan |
ZIP/POSTAL CODE |
46508 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Korea, South |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
Alicia Morris Groos |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
aoipdocket@nortonrosefulbright.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
alicia.groos@nortonrosefulbright.com; andrea.shannon@nortonrosefulbright.com; mary.murchison@nortonrosefulbright.com |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Alicia Morris Groos |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
aoipdocket@nortonrosefulbright.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
alicia.groos@nortonrosefulbright.com; andrea.shannon@nortonrosefulbright.com; mary.murchison@nortonrosefulbright.com |
DOCKET/REFERENCE NUMBER |
KIRN.T0025US |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations
for the prevention, diagnosis, and treatment of cancer |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
042 |
CURRENT IDENTIFICATION |
Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention,
diagnosis, and treatment of cancer |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
12/17/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
2 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
250 |
TOTAL AMOUNT |
250 |
SIGNATURE SECTION |
SIGNATURE |
/sangeun ju/ |
SIGNATORY'S NAME |
SangEun Ju |
SIGNATORY'S POSITION |
CEO |
DATE SIGNED |
11/18/2020 |
FILING INFORMATION |
SUBMIT DATE |
Tue Nov 17 22:18:36 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XX.XXX-2
0201117221836674137-88243
803-750f04550fdf4ec2613bd
4311fae95d2456345a7fc45b4
99aef41fc41ef8abba-CC-183
51609-2020111718223740183
6 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: LYZADDIS (see, http://uspto.report/TM/88243803/mark.png)
SERIAL NUMBER: 88243803
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: SillaJen, Inc., having an address of
Suite 607
6th Floor, 111, Hyoyeol-ro, Buk-gu
Busan, 46508
Korea, South
Email: XXXX
Proposed: SillaJen, Inc., having an address of
Suite 607
6th Floor, 111, Hyoyeol-ro, Buk-gu
Busan, 46508
Korea, South
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 12/17/2019.
For International Class 005:
Current identification: Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis,
and treatment of cancer
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 042:
Current identification: Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
Correspondence Information (current):
Alicia Morris Groos
PRIMARY EMAIL FOR CORRESPONDENCE: aoipdocket@nortonrosefulbright.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): alicia.groos@nortonrosefulbright.com; andrea.shannon@nortonrosefulbright.com; mary.murchison@nortonrosefulbright.com
Correspondence Information (proposed):
Alicia Morris Groos
PRIMARY EMAIL FOR CORRESPONDENCE: aoipdocket@nortonrosefulbright.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): alicia.groos@nortonrosefulbright.com; andrea.shannon@nortonrosefulbright.com; mary.murchison@nortonrosefulbright.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /sangeun ju/ Date Signed: 11/18/2020
Signatory's Name: SangEun Ju
Signatory's Position: CEO
RAM Sale Number: 88243803
RAM Accounting Date: 11/17/2020
Serial Number: 88243803
Internet Transmission Date: Tue Nov 17 22:18:36 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XXX-2020111722183667
4137-88243803-750f04550fdf4ec2613bd4311f
ae95d2456345a7fc45b499aef41fc41ef8abba-C
C-18351609-20201117182237401836